Profile
Alejandra Veronica Carvajal is currently the Director at Science Club For Girls, a Member of the Massachusetts Bar Association, and will be the Chief Legal Officer at CytomX Therapeutics, Inc. starting in 2026.
Former roles include Partner-R&D, Business Development & Manufacturing at Millennium Pharmaceuticals, Inc.; Secretary, Chief Legal Officer & General Counsel at Momenta Pharmaceuticals, Inc. from 2018 to 2021; Attorney at Day, Berry & Howard LLP; Attorney at Hill & Barlow, Inc.; Vice President & General Counsel at Cerulean Pharma, Inc. from 2014 to 2017; and Chief Legal Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2021 to 2026.
Education includes undergraduate studies at Harvard University and graduate studies at Georgetown University Law Center.
Alejandra Carvajal active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | General Counsel | 2026-08-02 |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Corporate Officer/Principal | - |
Science Club For Girls
Science Club For Girls Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides science, technology, engineering and mathematics support services | Director/Board Member | - |
Former positions of Alejandra Carvajal
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | General Counsel | 2026-01-05 |
| MOMENTA PHARMACEUTICALS, INC. | General Counsel | 2021-02-28 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | General Counsel | 2017-05-31 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Private Equity Analyst | - |
Hill & Barlow, Inc. | Corporate Officer/Principal | - |
Training of Alejandra Carvajal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Day, Berry & Howard LLP
Day, Berry & Howard LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Hill & Barlow, Inc. | Commercial Services |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Science Club For Girls
Science Club For Girls Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides science, technology, engineering and mathematics support services | Commercial Services |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Alejandra Carvajal
















